Does Amniocentesis Increase the Rates of Fetal Loss and Poor Pregnancy Outcomes?
Author(s) -
Önder Ercan,
Bülent Köstü,
Güven Arslan,
Murat Bakacak,
Alev Özer,
Deniz Cemgil Arıkan,
Kadın Hastalıkları,
Doğum Abd,
Tahir Burak
Publication year - 2016
Publication title -
the annals of clinical and analytical medicine
Language(s) - English
Resource type - Journals
ISSN - 2667-663X
DOI - 10.4328/jcam.4149
Subject(s) - medicine , amniocentesis , obstetrics , pregnancy , gynecology , fetus , prenatal diagnosis , genetics , biology
Aim: To evaluate the risk of fetal loss and poor pregnancy outcomes associated with amniocentesis procedures on patients in our clinic in the last 5 years. Material and Method: This retrospective study was conducted by examining the hospital records and genetic centre records of 387 patients who underwent amniocentesis at the Gynaecology and Obstetrics Clinic of Kahramanmaras Sutcu Imam University Medical Faculty between January 2011 and July 2015. A control group was formed of 250 low-risk patients who attended the clinic and did not have amniocentesis applied. Results:Throughout the study period there were 688 patients with an indication for amniocentesis. Of these, amniocentesis was applied to 387 patients and 43.8% refused the amniocentesis. The most common amniocentesis indication was the scanning test for Downs syndrome (57.6%) followed by older maternal age (22.5%). Of the patients who underwent amniocentesis, chromosomal abnormality was determined in 24 (6.2%), the most common of which was Downs syndrome (54%). Fetal loss following amniocentesis was seen in 2 patients (0.5%). When the total poor pregnancy outcomes were examined, a poor outcome was determined in 8 of the amniocentesis group and in 5 of the control group and the difference beween the 2 groups was not statistically significant (p=0.263). Discussion: Amniocentesis is an invasive prenatal test in frequent current use. No increase in pregnancy complications was observed associated with the procedure. Before the application of amniocentesis, the patient must be given detailed information about the procedure and the outcomes
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom